KLAS Global Reports Shed Positive Light on Intelerad Solutions

Montreal, Canada – November 15, 2016 – Intelerad Medical Systems™, the leader in enterprise workflows, specializing in diagnostic viewing, reporting, and collaboration solutions for hospitals, imaging centers and reading groups, have received high scores for product quality and support in two recent KLAS reports, including the Global PACS 2016 Report*.
 
“We are quite proud to have received such a high score from our clients, as it reflects our dedication to continually developing our solutions and providing the highest levels of support in our industry,” said Randall Oka, President & CEO, Intelerad. “In addition to 100% of clients surveyed stating they would buy from us again, it is also rewarding to see our growth in the hospital market being met with a great deal of enthusiasm and positive feedback from customers.”
 
Regarded in the report for offering great image quality and cutting-edge functionality, KLAS rated Intelerad favorably in terms of ease of use, delivery of new technology and overall product quality. Intelerad solutions were also positively rated for their functionality and the seamless workflow they provide. Meanwhile, customers expressed high levels of satisfaction for having their product feedback taken into consideration, and for moving products forward in ways that exceed expectations.
 
In regards to professional services, Intelerad customers reported constant satisfaction from the deployment phase through to everyday use. In terms of support, Intelerad received praise for their proactive, relationship-based support, and proactive services – Global (non-US).
 
In addition to the Global PACS 2016 Report, Intelerad received high scores for Global PACS - Northern America in the 2015/2016 Best in KLAS Global Software (non-US) report. The latter score was based on sales and contracting, implementation and training, functionality and upgrades, and service & support.
 
The KLAS report, Global PACS 2016 - An In-Depth Look at Product Quality and Support, is available at www.klasresearch.com.
 
*Based on preliminary data: Fewer than 15 of the interviewed clients were acute care organizations.
 
About Intelerad
Intelerad is the leader in enterprise workflows, specializing in diagnostic viewing, reporting, and collaboration solutions for hospitals, imaging centers and reading groups. Renowned for their innovative features and functionality, Intelerad solutions, such as InteleViewer™ and InteleOne® XE, increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments. Highly scalable, flexible and robust, Intelerad’s solutions offer high performance and industry-leading customer service and support. For more information, visit www.intelerad.com.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup